Dysbetalipoproteinemia
Also known as: Type III lipidemia / Type III lipidaemia / Remnant hyperlipidaemia / Dysbetalipoproteinaemia / Familial type 3 hyperlipoproteinemia (disorder) / Remnant hyperlipidemia / Type III hyperlipidemia / Type III hyperlipidaemia / Type III hyperlipoproteinaemia / Type III hyperlipoproteinemia / Hyperlipoproteinemia Type III
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB01076 | Atorvastatin | An HMG-CoA reductase inhibitor used to lower lipid levels and reduce the risk of cardiovascular disease including myocardial infarction and stroke. |
| DB00175 | Pravastatin | An HMG-CoA reductase inhibitor used to lower lipid levels and to reduce the risk of cardiovascular events, including myocardial infarction and stroke. |
| DB01098 | Rosuvastatin | An HMG-CoA reductase inhibitor used to lower lipid levels and reduce the risk of cardiovascular disease including myocardial infarction and stroke. |
| Drug | Drug Name | Phase | Status | Count |
|---|